Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)’s recommendations for cardiovascular risk management?

Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)’s recommendations for cardiovascular risk management?

Bibliographic Details
Main Authors:	Conrad, N, McInnes, IB, Mcmurray, JJV, Sattar, N
Format:	Journal article
Language:	English
Published:	BMJ Publishing 2022

Similar Items

Cardiovascular risk in systemic autoimmune diseases – authors' reply
by: Conrad, N, et al.
Published: (2023)

Characterisation of cardiovascular involvement in inflammatory arthropathies and systemic rheumatic diseases using multi-parametric cardiovascular magnetic resonance
by: Ntusi, N, et al.
Published: (2013)

AT-RISK: AuToimmune disorders and cardiovascular RISK
by: Conrad, N, et al.
Published: (2022)

HLA AND RHEUMATIC DISEASES
by: Wordsworth, B
Published: (1992)

Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases
by: Ntusi, N, et al.
Published: (2018)

Gout and incidence of 12 cardiovascular diseases: a case–control study including 152 663 individuals with gout and 709 981 matched controls
by: Ferguson, LD, et al.
Published: (2024)

American College of Rheumatology and European League Against Rheumatism 2017 Provisional Classification Criteria for Granulomatosis with Polyangiitis
by: Grayson, PC, et al.
Published: (2017)

The spectrum of inflammatory rheumatic disorders.
by: Walker-Bone, K, et al.
Published: (2000)

'Full-house' rheumatic heart disease.
by: Mathew, S, et al.
Published: (2007)

Macrophage heterogeneity in the context of rheumatic diseases
by: Udalova, I, et al.
Published: (2016)

The validity of surrogate markers in rheumatic disease.
by: Emery, P, et al.
Published: (1993)

Topical agents in the treatment of rheumatic pain.
by: Moore, R, et al.
Published: (2008)

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
by: Dasgupta, B, et al.
Published: (2012)

2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
by: Dasgupta, B, et al.
Published: (2012)

Soft-tissue rheumatic disorders of the neck and upper limb: prevalence and risk factors.
by: Walker-Bone, K, et al.
Published: (2003)

The prevalence and associated factors of clinical and subclinical rheumatic heart disease among rheumatic heart disease children admitted in HUSM
by: Zainol, Ahmad Rodzi
Published: (2015)

Mining the proteome associated with rheumatic and autoimmune diseases
by: Ruiz-Romero, C, et al.
Published: (2019)

Survival of Rheumatic Heart Disease in Indonesian Children
by: Arafuri, Nadya, et al.
Published: (2022)

Age-related mechanisms in the context of rheumatic disease
by: Alsaleh, G, et al.
Published: (2022)

Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK
by: Conrad, N, et al.
Published: (2022)

Eular recommendations for vasculitis
by: Luqmani, R, et al.
Published: (2007)

Mobile phone-based rheumatic heart disease detection
by: Springer, D
Published: (2015)

SOME APPLICATIONS OF THE NEW GENETICS TO THE INVESTIGATION OF THE RHEUMATIC DISEASES
by: Wordsworth, B
Published: (1992)

T-cell receptors and rheumatic disease: approaches to repertoire analysis.
by: Bowness, P, et al.
Published: (1992)

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
by: Mukhtyar, C, et al.
Published: (2008)

Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania.
by: Parks, T, et al.
Published: (2017)

Neglecting the neglected: the objective evidence of underfunding in rheumatic heart disease
by: Macleod, C, et al.
Published: (2019)

Screening for rheumatic diseases in the MS clinic: fulfilling the diagnostic criteria?
by: Rolinski, M, et al.
Published: (2009)

Complementary and alternative medicines (CAM) - Use in patients with rheumatic diseases.
by: Sandhu, S, et al.
Published: (2003)

The use of complementary and alternative medicines (CAM) in patients with rheumatic diseases
by: Famuboni, A, et al.
Published: (2003)

The human leukocyte antigen locus and rheumatic heart disease susceptibility in South Asians and Europeans
by: Auckland, K, et al.
Published: (2020)

Cardiovascular risk management: 6 Patients with type 2 diabetes and metabolic syndrome - Management recommendations for reducing cardiovascular risk
by: Hobbs, F, et al.
Published: (2011)

Arterial stiffness assessment in acute rheumatic fever; a pilot study
by: Hayati, Jaafar
Published: (2011)

Antinuclear antibodies in non-systemic autoimmune rheumatic disease dermatological conditions
by: Mahayidin, Hasni, et al.
Published: (2021)

Immunogenetics and rheumatic diseases: 25 years on from HLA-B27
by: Wordsworth, P
Published: (1999)

097 Are we using too much hydroxychloroquine in patients with rheumatic diseases?
by: Worth, C, et al.
Published: (2016)

Use of a computerised system to facilitate management of autoimmune rheumatic diseases
by: Luqmani, R, et al.
Published: (2017)

Development of a paediatric anxiety questionnaire (PAQ) in children with rheumatic diseases
by: Malone, P, et al.
Published: (2001)

Childhood cardiovascular risk factors and adult cardiovascular events
by: Jacobs, DR, et al.
Published: (2022)

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
by: Kristensen, SL, et al.
Published: (2019)